世界のエボラワクチン市場2020年:製造業者別、地域別、種類・用途別

【英語タイトル】Global Ebola Vaccine Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが出版した調査資料(GIR20SP00429)・商品コード:GIR20SP00429
・発行会社(調査会社):GlobalInfoResearch
・発行日:2020年9月18日(※2024年版があります。お問い合わせください)
・ページ数:101
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル
・産業分野:医療、製薬、バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥515,040見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥772,560見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,030,080見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートでは、エボラワクチンの世界市場を広く調査・分析し、今後の市場展望をまとめております。エボラワクチンの種類別市場規模(不活化ワクチン、DNAワクチン、ウイルスベクターワクチン、その他)、用途別市場規模(子供、成人)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・メーカー情報(販売量、市場シェア、製品概要、SWOT分析):Merck、Johnson & Johnson、CanSino Biologics Inc
・地域別グローバル市場分析 2015年-2020年
・エボラワクチンの北米市場(アメリカ、カナダ、メキシコ)
・エボラワクチンのヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・エボラワクチンのアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・エボラワクチンの南米市場(ブラジル、アルゼンチン)
・エボラワクチンの中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:不活化ワクチン、DNAワクチン、ウイルスベクターワクチン、その他
・用途別分析:子供、成人
・地域別市場規模予測 2021年-2025年
・販売チャネル、流通業者、代理店
・調査の結果・結論
【レポートの概要】

Market Overview
The Ebola Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The most likely (base case) scenario is that the global Ebola Vaccine sales will be xx in 2020 from Ebola Vaccine million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Ebola Vaccine market size is expected to grow at xx% or more annually for the next five years.

This report also researches and evaluates the impact of Covid-19 outbreak on the Ebola Vaccine industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Ebola Vaccine and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).

Market segmentation
Ebola Vaccine market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Ebola Vaccine market has been segmented into
Inactivated Vaccine
DNA Vaccine
Virus Vector Vaccine
Others

By Application, Ebola Vaccine has been segmented into:
For Children
For Adults

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Ebola Vaccine market presented in the report. This section sheds light on the sales growth of different regional and country-level Ebola Vaccine markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Ebola Vaccine market.

The report offers in-depth assessment of the growth and other aspects of the Ebola Vaccine market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Ebola Vaccine Market Share Analysis
Ebola Vaccine competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Ebola Vaccine sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Ebola Vaccine sales, revenue and market share for each player covered in this report.

The major players covered in Ebola Vaccine are:
Merck
Johnson & Johnson
CanSino Biologics Inc

Among other players domestic and global, Ebola Vaccine market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Ebola Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Ebola Vaccine, with price, sales, revenue and global market share of Ebola Vaccine in 2018 and 2019.
Chapter 3, the Ebola Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Ebola Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Ebola Vaccine market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Ebola Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.

【レポートの目次】

1 Market Overview
1.1 Ebola Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Ebola Vaccine Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Inactivated Vaccine
1.2.3 DNA Vaccine
1.2.4 Virus Vector Vaccine
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Ebola Vaccine Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 For Children
1.3.3 For Adults
1.4 Overview of Global Ebola Vaccine Market
1.4.1 Global Ebola Vaccine Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
1.6 COVID-19 Outbreak: Ebola Vaccine Industry Impact
1.6.1 COVID-19 Potential Implications for the Ebola Vaccine
1.6.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Ebola Vaccine
1.6.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.6.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.6.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.6.2 Opportunity Analysis in Covid-19 Crisis
1.6.3 Market Risk and Restraints
1.6.4 Market Driving Force
2 Manufacturers Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Merck SWOT Analysis
2.1.4 Merck Product and Services
2.1.5 Merck Ebola Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Johnson & Johnson
2.2.1 Johnson & Johnson Details
2.2.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Johnson & Johnson SWOT Analysis
2.2.4 Johnson & Johnson Product and Services
2.2.5 Johnson & Johnson Ebola Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 CanSino Biologics Inc
2.3.1 CanSino Biologics Inc Details
2.3.2 CanSino Biologics Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 CanSino Biologics Inc SWOT Analysis
2.3.4 CanSino Biologics Inc Product and Services
2.3.5 CanSino Biologics Inc Ebola Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Ebola Vaccine Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Ebola Vaccine Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Ebola Vaccine Manufacturer Market Share in 2019
3.3.2 Top 6 Ebola Vaccine Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Ebola Vaccine Sales, Revenue and Market Share by Regions
4.1.1 Global Ebola Vaccine Sales and Market Share by Regions (2015-2020)
4.1.2 Global Ebola Vaccine Revenue and Market Share by Regions (2015-2020)
4.2 North America Ebola Vaccine Sales and Growth Rate (2015-2020)
4.3 Europe Ebola Vaccine Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Ebola Vaccine Sales and Growth Rate (2015-2020)
4.5 South America Ebola Vaccine Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Ebola Vaccine Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Ebola Vaccine Sales, Revenue and Market Share by Country
5.1.1 North America Ebola Vaccine Sales and Market Share by Country (2015-2020)
5.1.2 North America Ebola Vaccine Revenue and Market Share by Country (2015-2020)
5.2 United States Ebola Vaccine Sales and Growth Rate (2015-2020)
5.3 Canada Ebola Vaccine Sales and Growth Rate (2015-2020)
5.4 Mexico Ebola Vaccine Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Ebola Vaccine Sales, Revenue and Market Share by Country
6.1.1 Europe Ebola Vaccine Sales and Market Share by Country (2015-2020)
6.1.2 Europe Ebola Vaccine Revenue and Market Share by Country (2015-2020)
6.2 Germany Ebola Vaccine Sales and Growth Rate (2015-2020)
6.3 UK Ebola Vaccine Sales and Growth Rate (2015-2020)
6.4 France Ebola Vaccine Sales and Growth Rate (2015-2020)
6.5 Russia Ebola Vaccine Sales and Growth Rate (2015-2020)
6.6 Italy Ebola Vaccine Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Ebola Vaccine Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Ebola Vaccine Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Ebola Vaccine Revenue and Market Share by Regions (2015-2020)
7.2 China Ebola Vaccine Sales and Growth Rate (2015-2020)
7.3 Japan Ebola Vaccine Sales and Growth Rate (2015-2020)
7.4 Korea Ebola Vaccine Sales and Growth Rate (2015-2020)
7.5 India Ebola Vaccine Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Ebola Vaccine Sales and Growth Rate (2015-2020)
7.7 Australia Ebola Vaccine Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Ebola Vaccine Sales, Revenue and Market Share by Country
8.1.1 South America Ebola Vaccine Sales and Market Share by Country (2015-2020)
8.1.2 South America Ebola Vaccine Revenue and Market Share by Country (2015-2020)
8.2 Brazil Ebola Vaccine Sales and Growth Rate (2015-2020)
8.3 Argentina Ebola Vaccine Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Ebola Vaccine Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Ebola Vaccine Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Ebola Vaccine Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Ebola Vaccine Sales and Growth Rate (2015-2020)
9.3 Turkey Ebola Vaccine Sales and Growth Rate (2015-2020)
9.4 Egypt Ebola Vaccine Sales and Growth Rate (2015-2020)
9.5 South Africa Ebola Vaccine Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Ebola Vaccine Sales and Market Share by Type (2015-2020)
10.2 Global Ebola Vaccine Revenue and Market Share by Type (2015-2020)
10.3 Global Ebola Vaccine Price by Type (2015-2020)
11 Global Ebola Vaccine Market Segment by Application
11.1 Global Ebola Vaccine Sales Market Share by Application (2015-2020)
11.2 Global Ebola Vaccine Revenue Market Share by Application (2015-2020)
11.3 Global Ebola Vaccine Price by Application (2015-2020)
12 Market Forecast
12.1 Global Ebola Vaccine Sales, Revenue and Growth Rate (2021-2025)
12.2 Ebola Vaccine Market Forecast by Regions (2021-2025)
12.2.1 North America Ebola Vaccine Market Forecast (2021-2025)
12.2.2 Europe Ebola Vaccine Market Forecast (2021-2025)
12.2.3 Asia-Pacific Ebola Vaccine Market Forecast (2021-2025)
12.2.4 South America Ebola Vaccine Market Forecast (2021-2025)
12.2.5 Middle East & Africa Ebola Vaccine Market Forecast (2021-2025)
12.3 Ebola Vaccine Market Forecast by Type (2021-2025)
12.3.1 Global Ebola Vaccine Sales Forecast by Type (2021-2025)
12.3.2 Global Ebola Vaccine Market Share Forecast by Type (2021-2025)
12.4 Ebola Vaccine Market Forecast by Application (2021-2025)
12.4.1 Global Ebola Vaccine Sales Forecast by Application (2021-2025)
12.4.2 Global Ebola Vaccine Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

List of Tables
Table 1. Global Ebola Vaccine Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Ebola Vaccine by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Ebola Vaccine Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Ebola Vaccine Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. Merck Basic Information, Manufacturing Base and Competitors
Table 9. Merck Ebola Vaccine Major Business
Table 10. Merck Ebola Vaccine Total Revenue (USD Million) (2018-2019)
Table 11. Merck SWOT Analysis
Table 12. Merck Ebola Vaccine Product and Services
Table 13. Merck Ebola Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 15. Johnson & Johnson Ebola Vaccine Major Business
Table 16. Johnson & Johnson Ebola Vaccine Total Revenue (USD Million) (2018-2019)
Table 17. Johnson & Johnson SWOT Analysis
Table 18. Johnson & Johnson Ebola Vaccine Product and Services
Table 19. Johnson & Johnson Ebola Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. CanSino Biologics Inc Basic Information, Manufacturing Base and Competitors
Table 21. CanSino Biologics Inc Ebola Vaccine Major Business
Table 22. CanSino Biologics Inc Ebola Vaccine Total Revenue (USD Million) (2018-2019)
Table 23. CanSino Biologics Inc SWOT Analysis
Table 24. CanSino Biologics Inc Ebola Vaccine Product and Services
Table 25. CanSino Biologics Inc Ebola Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. Global Ebola Vaccine Sales by Manufacturer (2018-2019) (K Units)
Table 27. Global Ebola Vaccine Revenue by Manufacturer (2018-2019) (USD Million)
Table 28. Global Ebola Vaccine Sales by Regions (2015-2020) (K Units)
Table 29. Global Ebola Vaccine Sales Market Share by Regions (2015-2020)
Table 30. Global Ebola Vaccine Revenue by Regions (2015-2020) (USD Million)
Table 31. North America Ebola Vaccine Sales by Countries (2015-2020) (K Units)
Table 32. North America Ebola Vaccine Sales Market Share by Countries (2015-2020)
Table 33. North America Ebola Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 34. North America Ebola Vaccine Revenue Market Share by Countries (2015-2020)
Table 35. Europe Ebola Vaccine Sales by Countries (2015-2020) (K Units)
Table 36. Europe Ebola Vaccine Sales Market Share by Countries (2015-2020)
Table 37. Europe Ebola Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 38. Asia-Pacific Ebola Vaccine Sales by Regions (2015-2020) (K Units)
Table 39. Asia-Pacific Ebola Vaccine Sales Market Share by Regions (2015-2020)
Table 40. Asia-Pacific Ebola Vaccine Revenue by Regions (2015-2020) (USD Million)
Table 41. South America Ebola Vaccine Sales by Countries (2015-2020) (K Units)
Table 42. South America Ebola Vaccine Sales Market Share by Countries (2015-2020)
Table 43. South America Ebola Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 44. South America Ebola Vaccine Revenue Market Share by Countries (2015-2020)
Table 45. Middle East & Africa Ebola Vaccine Sales by Countries (2015-2020) (K Units)
Table 46. Middle East & Africa Ebola Vaccine Sales Market Share by Countries (2015-2020)
Table 47. Middle East & Africa Ebola Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 48. Middle East & Africa Ebola Vaccine Revenue Market Share by Countries (2015-2020)
Table 49. Global Ebola Vaccine Sales by Type (2015-2020) (K Units)
Table 50. Global Ebola Vaccine Sales Share by Type (2015-2020)
Table 51. Global Ebola Vaccine Revenue by Type (2015-2020) (USD Million)
Table 52. Global Ebola Vaccine Revenue Share by Type (2015-2020)
Table 53. Global Ebola Vaccine Sales by Application (2015-2020) (K Units)
Table 54. Global Ebola Vaccine Sales Share by Application (2015-2020)
Table 55. Global Ebola Vaccine Sales Forecast by Regions (2021-2025) (K Units)
Table 56. Global Ebola Vaccine Market Share Forecast by Regions (2021-2025)
Table 57. Global Ebola Vaccine Sales Forecast by Type (2021-2025) (K Units)
Table 58. Global Ebola Vaccine Market Share Forecast by Type (2021-2025)
Table 59. Global Ebola Vaccine Sales Forecast by Application (2021-2025)
Table 60. Global Ebola Vaccine Market Share Forecast by Application (2021-2025)
Table 61. Direct Channel Pros & Cons
Table 62. Indirect Channel Pros & Cons
Table 63. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Ebola Vaccine Picture
Figure 2. Global Sales Market Share of Ebola Vaccine by Type in 2019
Figure 3. Inactivated Vaccine Picture
Figure 4. DNA Vaccine Picture
Figure 5. Virus Vector Vaccine Picture
Figure 6. Others Picture
Figure 7. Ebola Vaccine Sales Market Share by Application in 2018
Figure 8. For Children Picture
Figure 9. For Adults Picture
Figure 10. Global Ebola Vaccine Market Status and Outlook (2015-2025) (USD Million)
Figure 11. United States Ebola Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Canada Ebola Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Mexico Ebola Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Germany Ebola Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 15. France Ebola Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 16. UK Ebola Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Russia Ebola Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Italy Ebola Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 19. China Ebola Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Japan Ebola Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Korea Ebola Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 22. India Ebola Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Southeast Asia Ebola Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Australia Ebola Vaccine Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 25. Brazil Ebola Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Egypt Ebola Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Saudi Arabia Ebola Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 28. South Africa Ebola Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Turkey Ebola Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Global Ebola Vaccine Sales Market Share by Manufacturer in 2019
Figure 31. Global Ebola Vaccine Revenue Market Share by Manufacturer in 2019
Figure 32. Top 3 Ebola Vaccine Manufacturer (Revenue) Market Share in 2019
Figure 33. Top 6 Ebola Vaccine Manufacturer (Revenue) Market Share in 2019
Figure 34. Key Manufacturer Market Share Trend
Figure 35. Global Ebola Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 36. Global Ebola Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 37. Global Ebola Vaccine Revenue Market Share by Regions (2015-2020)
Figure 38. Global Ebola Vaccine Revenue Market Share by Regions in 2018
Figure 39. North America Ebola Vaccine Sales and Growth Rate (2015-2020)
Figure 40. Europe Ebola Vaccine Sales and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Ebola Vaccine Sales and Growth Rate (2015-2020)
Figure 42. South America Ebola Vaccine Sales and Growth Rate (2015-2020)
Figure 43. Middle East & Africa Ebola Vaccine Sales and Growth Rate (2015-2020)
Figure 44. North America Ebola Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 45. North America Ebola Vaccine Sales Market Share by Countries (2015-2020)
Figure 46. North America Ebola Vaccine Sales Market Share by Countries in 2018
Figure 47. North America Ebola Vaccine Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 48. North America Ebola Vaccine Revenue Market Share by Countries in 2018
Figure 49. United States Ebola Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Canada Ebola Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Mexico Ebola Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 52. Europe Ebola Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 53. Europe Ebola Vaccine Revenue Market Share by Countries (2015-2020)
Figure 54. Europe Ebola Vaccine Revenue Market Share by Countries in 2019
Figure 55. Germany Ebola Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 56. UK Ebola Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 57. France Ebola Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Russia Ebola Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Italy Ebola Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 60. Asia-Pacific Ebola Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 61. Asia-Pacific Ebola Vaccine Sales Market Share by Regions 2019
Figure 62. Asia-Pacific Ebola Vaccine Revenue Market Share by Regions 2019
Figure 63. China Ebola Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Japan Ebola Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Korea Ebola Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 66. India Ebola Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 67. Southeast Asia Ebola Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 68. South America Ebola Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 69. South America Ebola Vaccine Sales Market Share by Countries in 2019
Figure 70. South America Ebola Vaccine Revenue Market Share by Countries in 2019
Figure 71. Brazil Ebola Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 72. Argentina Ebola Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 73. Middle East and Africa Ebola Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 74. Middle East and Africa Ebola Vaccine Sales Market Share by Countries in 2019
Figure 75. Middle East and Africa Ebola Vaccine Revenue Market Share by Countries (2015-2020)
Figure 76. Middle East and Africa Ebola Vaccine Revenue Market Share by Countries in 2019
Figure 77. Saudi Arabia Ebola Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 78. Egypt Ebola Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Turkey Ebola Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 80. South Africa Ebola Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 81. Global Ebola Vaccine Sales and Growth Rate (2021-2025) (K Units)
Figure 82. Global Ebola Vaccine Revenue and Growth Rate (2021-2025) (USD Million)
Figure 83. North America Sales Ebola Vaccine Market Forecast (2021-2025) (K Units)
Figure 84. Europe Sales Ebola Vaccine Market Forecast (2021-2025) (K Units)
Figure 85. Asia-Pacific Sales Ebola Vaccine Market Forecast (2021-2025) (K Units)
Figure 86. South America Sales Ebola Vaccine Market Forecast (2021-2025) (K Units)
Figure 87. Middle East & Africa Sales Ebola Vaccine Market Forecast (2021-2025) (K Units)
Figure 88. Sales Channel: Direct Channel vs Indirect Channel


【掲載企業】

Merck、Johnson & Johnson、CanSino Biologics Inc

★調査レポート[世界のエボラワクチン市場2020年:製造業者別、地域別、種類・用途別] (コード:GIR20SP00429)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のエボラワクチン市場2020年:製造業者別、地域別、種類・用途別]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆